Logo image of CGX.CA

CINEPLEX INC (CGX.CA) Stock Fundamental Analysis

TSX:CGX - Toronto Stock Exchange - CA1724541000 - Common Stock - Currency: CAD

10.99  -0.13 (-1.17%)

Fundamental Rating

4

Taking everything into account, CGX scores 4 out of 10 in our fundamental rating. CGX was compared to 14 industry peers in the Entertainment industry. While CGX is still in line with the averages on profitability rating, there are concerns on its financial health. CGX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CGX had negative earnings in the past year.
CGX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CGX reported negative net income in multiple years.
Of the past 5 years CGX 4 years had a positive operating cash flow.
CGX.CA Yearly Net Income VS EBIT VS OCF VS FCFCGX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.71%, CGX belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
CGX has a Return On Invested Capital of 3.19%. This is amongst the best in the industry. CGX outperforms 92.86% of its industry peers.
CGX had an Average Return On Invested Capital over the past 3 years of 3.36%. This is in line with the industry average of 3.76%.
Industry RankSector Rank
ROA -3.71%
ROE N/A
ROIC 3.19%
ROA(3y)1.91%
ROA(5y)-6.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.36%
ROIC(5y)N/A
CGX.CA Yearly ROA, ROE, ROICCGX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

CGX's Operating Margin of 5.69% is amongst the best of the industry. CGX outperforms 100.00% of its industry peers.
CGX's Operating Margin has declined in the last couple of years.
The Gross Margin of CGX (67.17%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of CGX has remained more or less at the same level.
Industry RankSector Rank
OM 5.69%
PM (TTM) N/A
GM 67.17%
OM growth 3YN/A
OM growth 5Y-3.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.37%
CGX.CA Yearly Profit, Operating, Gross MarginsCGX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CGX is destroying value.
CGX has less shares outstanding than it did 1 year ago.
CGX has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for CGX has been reduced compared to a year ago.
CGX.CA Yearly Shares OutstandingCGX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CGX.CA Yearly Total Debt VS Total AssetsCGX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

CGX has an Altman-Z score of 0.02. This is a bad value and indicates that CGX is not financially healthy and even has some risk of bankruptcy.
CGX has a Altman-Z score (0.02) which is comparable to the rest of the industry.
CGX has a debt to FCF ratio of 111.23. This is a negative value and a sign of low solvency as CGX would need 111.23 years to pay back of all of its debts.
CGX's Debt to FCF ratio of 111.23 is fine compared to the rest of the industry. CGX outperforms 78.57% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 111.23
Altman-Z 0.02
ROIC/WACC0.48
WACC6.71%
CGX.CA Yearly LT Debt VS Equity VS FCFCGX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.25 indicates that CGX may have some problems paying its short term obligations.
CGX has a Current ratio of 0.25. This is comparable to the rest of the industry: CGX outperforms 42.86% of its industry peers.
CGX has a Quick Ratio of 0.25. This is a bad value and indicates that CGX is not financially healthy enough and could expect problems in meeting its short term obligations.
CGX has a Quick ratio (0.21) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.21
CGX.CA Yearly Current Assets VS Current LiabilitesCGX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

CGX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -412.50%.
CGX shows a decrease in Revenue. In the last year, the revenue decreased by -3.18%.
Measured over the past years, CGX shows a decrease in Revenue. The Revenue has been decreasing by -4.39% on average per year.
EPS 1Y (TTM)-412.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-825%
Revenue 1Y (TTM)-3.18%
Revenue growth 3Y26.54%
Revenue growth 5Y-4.39%
Sales Q2Q%-10.34%

3.2 Future

The Earnings Per Share is expected to grow by 88.17% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.33% on average over the next years.
EPS Next Y178.75%
EPS Next 2Y88.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.74%
Revenue Next 2Y6.14%
Revenue Next 3Y5.33%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGX.CA Yearly Revenue VS EstimatesCGX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CGX.CA Yearly EPS VS EstimatesCGX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CGX. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 12.09, which indicates a correct valuation of CGX.
Based on the Price/Forward Earnings ratio, CGX is valued cheaper than 92.86% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CGX to the average of the S&P500 Index (36.21), we can say CGX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 12.09
CGX.CA Price Earnings VS Forward Price EarningsCGX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CGX is valued a bit cheaper than 78.57% of the companies in the same industry.
CGX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CGX is cheaper than 78.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 42.72
EV/EBITDA 9.99
CGX.CA Per share dataCGX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

CGX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CGX's earnings are expected to grow with 88.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y88.17%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CGX!.
Industry RankSector Rank
Dividend Yield N/A

CINEPLEX INC

TSX:CGX (8/1/2025, 7:00:00 PM)

10.99

-0.13 (-1.17%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-12 2025-08-12
Inst Owners29.68%
Inst Owner ChangeN/A
Ins Owners1.98%
Ins Owner ChangeN/A
Market Cap697.21M
Analysts78
Price Target13.52 (23.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-58.05%
Min EPS beat(2)-87.06%
Max EPS beat(2)-29.05%
EPS beat(4)1
Avg EPS beat(4)-125.97%
Min EPS beat(4)-413.09%
Max EPS beat(4)25.32%
EPS beat(8)3
Avg EPS beat(8)-654.2%
EPS beat(12)6
Avg EPS beat(12)-390.53%
EPS beat(16)7
Avg EPS beat(16)-297.94%
Revenue beat(2)0
Avg Revenue beat(2)-4.99%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-4.59%
Revenue beat(4)1
Avg Revenue beat(4)-2.71%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)1.26%
Revenue beat(8)4
Avg Revenue beat(8)-2.3%
Revenue beat(12)8
Avg Revenue beat(12)-0.68%
Revenue beat(16)11
Avg Revenue beat(16)0.25%
PT rev (1m)0%
PT rev (3m)1.27%
EPS NQ rev (1m)-48.65%
EPS NQ rev (3m)175%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-1.42%
Revenue NQ rev (3m)-0.43%
Revenue NY rev (1m)-0.97%
Revenue NY rev (3m)-1.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.09
P/S 0.54
P/FCF 42.72
P/OCF 6.94
P/B N/A
P/tB N/A
EV/EBITDA 9.99
EPS(TTM)-1.25
EYN/A
EPS(NY)0.91
Fwd EY8.27%
FCF(TTM)0.26
FCFY2.34%
OCF(TTM)1.58
OCFY14.41%
SpS20.49
BVpS-1.17
TBVpS-12.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.71%
ROE N/A
ROCE 4.43%
ROIC 3.19%
ROICexc 3.23%
ROICexgc 5.61%
OM 5.69%
PM (TTM) N/A
GM 67.17%
FCFM 1.26%
ROA(3y)1.91%
ROA(5y)-6.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.36%
ROIC(5y)N/A
ROICexc(3y)3.46%
ROICexc(5y)N/A
ROICexgc(3y)5.89%
ROICexgc(5y)N/A
ROCE(3y)4.66%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y2.1%
ROICexc growth 3YN/A
ROICexc growth 5Y0.06%
OM growth 3YN/A
OM growth 5Y-3.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.37%
F-Score4
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 111.23
Debt/EBITDA 6.88
Cap/Depr 47.87%
Cap/Sales 6.47%
Interest Coverage 0.54
Cash Conversion 40.23%
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.21
Altman-Z 0.02
F-Score4
WACC6.71%
ROIC/WACC0.48
Cap/Depr(3y)39.73%
Cap/Depr(5y)33.4%
Cap/Sales(3y)5.83%
Cap/Sales(5y)8.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-412.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-825%
EPS Next Y178.75%
EPS Next 2Y88.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.18%
Revenue growth 3Y26.54%
Revenue growth 5Y-4.39%
Sales Q2Q%-10.34%
Revenue Next Year5.74%
Revenue Next 2Y6.14%
Revenue Next 3Y5.33%
Revenue Next 5YN/A
EBIT growth 1Y-45.4%
EBIT growth 3YN/A
EBIT growth 5Y-7.81%
EBIT Next Year216.27%
EBIT Next 3Y55.93%
EBIT Next 5Y28.45%
FCF growth 1Y-51.94%
FCF growth 3Y41.4%
FCF growth 5Y-13.75%
OCF growth 1Y-13.19%
OCF growth 3Y38.48%
OCF growth 5Y-12.79%